FormFactor, Inc. (FORM) Company Overview

FormFactor, Inc. is a Nasdaq-listed semiconductor test and measurement company operating as FORM. It supplies precision interfaces and systems used to contact, measure, and validate wafers and die from research through high-volume production. Products include advanced probe cards, analytical probes, probe stations, thermal subsystems, and cryogenic systems. FormFactor is therefore an enabling supplier to foundries, memory manufacturers, chip designers, laboratories, and quantum-computing developers rather than a chip producer.

The official company overview emphasizes a large installed base and global service network. More important, FormFactor sells high-specification engineering tools and custom production interfaces into qualification-heavy workflows. Revenue depends on device roadmaps, customer production ramps, and test complexity per wafer.

Where does FormFactor fit in the semiconductor value chain?

Which end markets matter?

FormFactor serves foundry and logic, DRAM, flash, photonics, power semiconductors, sensors, and quantum applications. HBM memory stacks require demanding wafer test, while co-packaged optics adds optical alignment and measurement. FY2025 revenue was geographically concentrated in South Korea at 30.3%, Taiwan at 25.8%, and the United States at 19.4%. That mix follows advanced semiconductor manufacturing but raises trade, export-control, currency, and customer risks.

FormFactor reports two segments: Probe Cards and Systems. Probe Cards is the larger, higher-margin engine, with custom products tied to design wins, qualification, production volumes, and replacement demand. Systems sells probe stations, analytical probes, thermal and cryogenic platforms, software, installation, and support, giving FormFactor exposure earlier in the development cycle.

Why do probe cards dominate the economics?

Advanced probe cards must contact dense pads, bumps, or pillars with precise signal integrity, current capacity, parallelism, and durability. Long customer evaluations and heavy MEMS investment create barriers to entry and switching friction. The offset is product specificity: demand can change quickly when a chip program is delayed, redesigned, or moved.

How does Systems extend the model from lab to fab?

The FY2025 Form 10-K shows Probe Cards produced 81.3% of full-year revenue, making Systems a strategic extension rather than the main current earnings source.

The latest reported period as of July 25, 2026 is Q1 FY2026, ended March 28, 2026. FormFactor posted a second consecutive revenue record: sales rose 5.1% sequentially and 32.0% year over year, led by Foundry & Logic and DRAM. Strong demand coexisted with restructuring and factory-transition costs, so operating momentum looked better than GAAP gross margin alone.

Which figures define Q1 FY2026?

Why did GAAP and non-GAAP margins diverge?

Q1 FY2026 included $23.3M of restructuring charges, with $21.5M in cost of revenue, plus $7.1M of factory start-up expense. GAAP gross margin was 38.4% versus 49.0% non-GAAP. The adjustments obscure underlying product margin, but they still represent real transition costs. The Q1 earnings release and Form 10-Q provide the current detail.

FormFactor's strongest near-term demand comes from rising test intensity in advanced computing. HBM stacks multiple DRAM die, increasing interfaces, tolerances, and the cost of an undetected defect. Q1 FY2026 Foundry & Logic benefited from networking and high-performance-compute processors, while Systems declined during the transition from legacy stations to the Triton co-packaged-optics platform.

Why does HBM increase test value?

Stacking known-good die makes upstream HBM screening more valuable. FormFactor's high pin counts, dense contacts, current delivery, and signal integrity can earn more test content as complexity rises. Q1 FY2026 DRAM revenue was $82.9M, up 69.7% year over year. The risk is concentration: SK hynix represented 22.9% of FY2025 revenue.

How could co-packaged optics expand the Systems opportunity?

Co-packaged optics brings optical connectivity closer to processors and requires coordinated optical and electrical measurement. The December 2025 Keystone Photonics acquisition added silicon-photonics probing technology. FormFactor paid $20.6M net cash, recording $15.1M of goodwill and $8.4M of intangibles. The official announcement positions Keystone as a bridge from engineering test toward production.

FormFactor evolved from a specialized MEMS probe-card supplier into a broader electrical, optical, thermal, and cryogenic measurement platform. These turning points explain today's segments and capital needs.

1. 1993
   FormFactor was founded and established an early MEMS fabrication capability. That manufacturing know-how remains central to advanced probe cards.
2. 1994
   The first MicroSpring probe card shipped, establishing the custom wafer-test interface around which the production business developed.
3. 2003
   The initial public offering provided access to public capital and supported expansion beyond an entrepreneurial equipment supplier.
4. 2012
   The MicroProbe acquisition strengthened advanced probe-card scale and customer reach, reinforcing the business that still produces most revenue.
5. 2016
   The Cascade Microtech acquisition added probe stations, analytical probes, and thermal systems, creating today's Systems segment and lab-to-fab strategy.
6. 2025
   A $67.2M equity investment in FICT deepened exposure to probe-card substrates and manufacturing capabilities, adding supply-chain integration and investment risk.
7. 2025
   FormFactor acquired and began building out a 283,495-square-foot facility in Farmers Branch, Texas, expanding capacity in a lower-cost region.
8. 2025
   Keystone Photonics expanded optical probing capabilities, supporting the strategic push into silicon photonics and co-packaged optics.

The company's official history provides the early milestones, while the Cascade acquisition release explains the decisive move into engineering systems.

Why was Cascade Microtech the strategic inflection point?

Cascade added installed systems, analytical probes, software, thermal tools, and application expertise used earlier in development. That created a lab-to-fab feedback loop: engineers learn customer measurement problems before production ramps. It also added a lower-margin, equipment-cycle-sensitive segment, so diversification did not guarantee smoother earnings.

What do the 2025 investments change?

FICT, Farmers Branch, and Keystone build materials access, manufacturing capacity, and optical capability. The goal is better control of inputs, room for HBM growth, and a broader photonics solution. The cost appears in capex, start-up expense, restructuring, and integration risk; returns depend on revenue and gross profit ramping fast enough.

FormFactor's moat is a system of technical resources: custom MEMS designs, process knowledge, application engineers, qualification history, installed systems, service, and customer roadmap access. The 10-K says no single patent is essential; development speed, trade secrets, market penetration, and support matter as much. The advantage is an organized capability, not one isolated asset.

Which barriers to entry matter most?

The filing cites high MEMS development costs and long customer evaluations as barriers. A qualified probe card sits in a critical production step, where reliability, contact accuracy, parallelism, cleaning behavior, lifetime, and signal integrity can outweigh price. Global engineering support adds switching friction without eliminating bidding pressure.

Where is competition strongest?

Supplier and buyer power remain significant. Some substrates, circuit boards, contact elements, and interconnects have limited sources, while large semiconductor customers influence price, qualification, and volume. FormFactor must keep investing in R&D and service to preserve its moat.

FormFactor entered 2026 with substantial liquidity, modest debt, and positive operating cash flow, but expansion burdened free cash flow. FY2025 revenue was $785.0M, operating income $57.1M, and net income $54.4M. Operating cash flow of $115.4M less $103.7M of capex produced roughly $11.7M of simple free cash flow, reflecting investment rather than weak operating cash generation.

What does cash conversion show?

How much balance-sheet flexibility remains?

Why is Farmers Branch the central capital-allocation test?

The Texas facility is expected to begin probe-card production in late FY2026. FormFactor estimated total buildout and ramp capital of $140M–$170M, with $55.0M spent in FY2025. The official facility announcement ties the project to advanced probe-card capacity. The valuation test is whether HBM and foundry demand convert this spending into durable margin and return on capital.

FormFactor has one common share class with one vote per share and no founder or dual-class control. The 2026 proxy reported 77,954,440 shares outstanding on March 16, 2026. BlackRock, Vanguard, and EARNEST Partners were the disclosed holders above 5%, while directors and executives as a group owned less than 1%. Governance is therefore institutionally influenced but broadly public.

The 2026 proxy is the disclosure source; underlying Schedule 13G dates differ by holder, so these are not same-day trading positions.

How is the board structured?

What do executive incentives emphasize?

The 2025 incentive design placed 70% of the company financial component on adjusted operating income, with shareholder return also important. That fits the current challenge of funding growth while recovering margins. Ownership guidelines require the CEO to hold the greater of 10,000 shares or three times salary, and other executives 10,000 shares or two times salary.

The opportunity rests on rising test complexity, not chip unit growth alone. HBM, advanced packaging, high-performance logic, silicon photonics, power devices, and cryogenic computing can increase measurement value. Farmers Branch could add capacity and lower costs. Offsetting risks include customer concentration, cycles, tariffs, export controls, platform transitions, supply constraints, and factory execution.

Which opportunities have the clearest operating evidence?

HBM has the clearest evidence: Q1 FY2026 DRAM revenue rose 69.7% year over year, and FormFactor ships in volume to all three major HBM manufacturers. Foundry & Logic grew 30.4%. Photonics is earlier-stage; Keystone broadens capability, but the legacy-station decline shows that platform transitions can create revenue gaps.

Which risks have the most direct financial impact?

These risks map directly to financial statements: a delayed ramp lowers absorption, tariffs compress gross margin, and obsolete custom inventory creates charges. FormFactor's next update is scheduled for July 29, 2026, according to its Q2 reporting announcement.

FormFactor occupies a technically demanding bottleneck between chip design and reliable production. Custom probe cards drive current economics; Systems extends the platform into engineering, thermal, photonics, and cryogenic measurement. The central tension is record HBM and logic demand alongside heavy spending on capacity, manufacturing changes, and future optical test.

Which variables matter most in a DCF?

What should students, researchers, and investors monitor next?

• Whether quarterly revenue remains above the FY2025 run rate after the HBM-driven surge.
• Probe Cards gross margin and utilization as Farmers Branch begins production.
• The gap between GAAP and non-GAAP margin after restructuring charges decline.
• Systems recovery as Triton co-packaged-optics tools move from evaluation toward volume use.
• Free cash flow after the current capex cycle, not only operating cash flow.
• Customer concentration, especially the share of revenue tied to major HBM manufacturers.
• Tariff and export-control effects on gross margin and regional sales.
• Returns from Keystone, FICT, and the Texas capacity investment relative to their cash cost.